Molecular profiling of cancer genomes {#S0001}
=====================================

Over the years, individual laboratories and large-scale projects such as TCGA and ICGC have discovered that cancer is a heterogeneous disease with lots of variability within a single tumour type or even within a single tumour \[[@CIT0001]--[@CIT0004]\]. Nonetheless, much of our current understanding of cancer genetics is grounded on the principle that cancer arises from a clone that has accumulated the requisite somatically acquired genetic aberrations leading to the malignant transformation \[[@CIT0005]\]. Characterising individual tumours or cohorts at the molecular level has helped in identifying common and type specific cancer vulnerabilities as well as recording the individual history of tumours \[[@CIT0004], [@CIT0006]--[@CIT0008]\]. This has enabled the creation of drugs that target these molecular vulnerabilities and provide tailored treatments for patients, improving therapy efficacy and minimising its side effects \[[@CIT0009], [@CIT0010]\]. For example, Imatinib specifically targets the BCR-Abl fusion tyrosine kinase that exists only in the cells of chronic myelogenous leukaemia and other tumours but not in healthy cells \[[@CIT0011]\]. Similarly, Herceptin is a monoclonal antibody that is used to target HER2 positive breast tumours \[[@CIT0012]\].

At present, the TCGA and other large-scale projects characterise tumours with microarray and next generation sequencing (NGS) platforms to obtain a different type of genetic information at the whole genome level \[[@CIT0006]--[@CIT0008], [@CIT0013]--[@CIT0015]\]. The microarray platform had been, and is currently being, used to identify gene and microRNA expression, alternative splicing, copy number alterations, DNA methylation, and identification of protein-DNA and protein-RNA interactions \[[@CIT0016]\]. Next generation sequencing platforms are now replacing the microarray platforms for obtaining these data. Moreover, sequence reads from whole exome sequencing, along with DNA and RNA sequencing, also allow detection of mutations and gene fusions for coding and non-coding regions of the genome \[[@CIT0017]\]. While conceptually similar in experiment design, the sequence read information generated using NGS platforms has very different statistical properties to intensity-based information acquired from microarray platforms \[[@CIT0018]\].

Multiple articles have reviewed protocols to generate microarray profiles and their statistical analysis to extract meaningful information \[[@CIT0019]--[@CIT0022]\]. While relatively new, a vast amount literature describing statistical methodologies to analyse NGS data already exists \[[@CIT0023]--[@CIT0028]\]. So, in this article we focus only on the methodologies to extract meaningful information from NGS reads. Moreover, we will discuss only those data types that are generated and analysed by TCGA. Furthermore, for each data type, we only describe the main steps to obtain this information and point the readers to an exhaustive list of methodologies/software and articles for deeper insight. Also, we do not provide any comments on comparison of these methods but rather point to articles comparing different methodologies and identifying their strengths and errors \[[@CIT0029]--[@CIT0032]\].

Pre-processing and Quality Control of NGS data {#S0002}
==============================================

To date, several next-generation sequencing platforms are available, including the Illumina Genome Analyser, which is being used extensively TCGA by consortium for tumour profiling. Each platform has its own method for generating sequencing reads from samples. But in every case, the sequence reads obtained using these platforms are short -- typically from 36 to several hundred nucleotides. Furthermore the sequencing run can be single-end or paired-end, meaning the reads are sequenced in one or two directions (from 3' and 5' ends). The first tasks in any NGS computational pipeline are: performing primary data acquisition, determining base calls and confidence scores from the fluorescent signals of the sequencer, and converting them to FASTQ files containing the raw sequence reads and per base quality scores. When multiple samples are pooled in one lane using sample-specific index/barcode adapters, the FASTQ should be demultiplexed and reorganised based on index information, and the adapters ought to be trimmed \[[@CIT0033]\].

Quality control is a very important part of the data preparation ([Table 1](#T0001){ref-type="table"}). There are several kinds of sequencing artefacts that could have a serious negative impact on downstream analyses. The artefacts commonly exist in raw reads, regardless of the sequencing platform. Firstly, sequences may be contaminated with adapters on their 5′- or 3′ ends that were added as part of the sequencing protocol. Secondly, base quality and sequence complexity vary both within and between reads. The qualities of bases on most sequencing platforms will degrade as the run progresses, so it is common to see the quality of base calls falling towards the end of the read. It is desirable to remove or trim such sequences with appropriate thresholds. Additionally, NGS reads can be highly redundant with the same sequence being represented in large numbers, so it is important to reduce these PCR amplification artefacts. The contamination in the sequencing dataset can also be caused by laboratory factors such as sample preparation, library construction, and other steps of the experiment. Moreover, samples may contain DNA/RNA from other sources including viruses, which are hard to avoid during the sample preparation process. Finally, general statistical methods like sample clustering and principal component analysis (PCA), and outlier detection can be used for assessment of overall quality and sample comparison according to experiment design.

###### 

Software for primary quality control of NGS data

  Method name   Year published   PMID       Data type       Platform   Statistical method                                                                            Input requirements
  ------------- ---------------- ---------- --------------- ---------- --------------------------------------------------------------------------------------------- --------------------
  BIGpre        2011             22289480   Illumina, 454   Perl       Correlation between forward and reverse reads, trimming low-quality reads                     FASTQ
  FastQC        2010             --         any             Java       Sequence length, quality, k-mers presence reports                                             FASTQ, SAM/BAM
  HTQC          2013             23363224   Illumina        C++        Tail trimming, filter by quality/length/tile                                                  FASTQ
  QC-Chain      2013             23565205   any             C++        Quality assessment, trimming, filtering unknown contamination                                 FASTQ
  Qualimap      2012             22914218   any             Java, R    Alignment biases detection, sample comparison                                                 SAM/BAM
  PRINSEQ       2011             21278185   any             Perl       Sequence complexity, duplicates, occurrence of Ns and poly-A/T tails, tag sequences reports   FASTQ, FASTA
  PIQA          2009             19602525   Illumina        R          Assess the clusters density per tile, base-calls proportions per tile/cycle                   FASTQ
  FastUniq      2012             23284954   any             C++        De novo PCR duplicates removal for paired short reads                                         FASTQ

Aligning short reads to the reference genome {#S0003}
============================================

Accurate alignment of short sequence reads generated using NGS platforms to a repeat masked reference genome is the first step in obtaining biological information from NGS data. Since, the numbers of reads generated in any given NGS experiment are very large (typically in millions), many efficient algorithms have been developed to deal with the alignment process. It is important to note that different read mapping procedures are necessary depending on the needs of downstream analysis, and alignment accuracy has a high impact on the interpretation of the data. We comment on that in sections to follow. Most applications aim to identify uniquely mapped reads - matching to a single "best" genomic position. The non-uniquely mapped reads are filtered using an upper boundary for the number of reported mappings.

Most short read alignment algorithms use auxiliary data structures (also called indexes) for the reads or reference sequence. The main indexing methods are based on hash tables, prefix/suffix trees, or merge sorting methods ([Table 2](#T0002){ref-type="table"}). Such representation of the entire human genome takes only a few GB of memory and enables exact matches to be found in a short time. Burrow-Wheeler transform and FM-index-based algorithms give better results for reads from repeated regions, but there is no efficient general method for handling errors in the reads for this category. Some hybrid solutions have been proposed, e.g. Stampy (see [Table 2](#T0002){ref-type="table"}). These enhancements result in higher sensitivity and smaller memory requirements of mapping tools. Reported mapping positions are particularly useful as they prevent the result list being blown up by reads mapping to highly repetitive regions. It is important to note that in the case of paired-end sequencing the paired reads need to be mapped to identical genomic positions to be considered multi-mapping reads. Data from Illumina\'s machine has few substitution errors per read and virtually no insertion or deletion (INDELs) errors \[[@CIT0034]\]. Thus, it can be mapped efficiently by, for example, Bowtie \[[@CIT0035]\], and then its junction-mapping extension can be done by Tophat \[[@CIT0036]\], which can handle up to three mismatches per sequence and no INDELs.

###### 

Software for mapping sequence reads to genome

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Method name         Year published   PMID       Data type   Platform              Statistical method                                                                                                                                                                                                                        Input requirements
  ------------------- ---------------- ---------- ----------- --------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------
  BFAST               2009             19907642   RNA         C                     Based on creating flexible, efficient whole genome indexes to rapidly map reads to candidate alignment locations, with arbitrary multiple independent indexes allowed to achieve robustness against read errors and sequence variants.\   FASTQ
                                                                                    Final local alignment uses a Smith-Waterman method, with gaps to support the detection of small INDELs                                                                                                                                    

  Bowtie              2009             19261174   RNA         C++ (SeqAn library)   Bowtie extends previous Burrows-Wheeler techniques with a novel quality-aware backtracking algorithm that permits mismatches                                                                                                              FASTQ, FASTA

  BWA                 2009             19451168   RNA         C                     Backward search with Burrows-Wheeler Transform (BWT), allowing mismatches and gaps.                                                                                                                                                       FASTQ

  BWA-PSSM            2014             24717095   RNA         C                     Probabilistic adaptable alignment based on the use of position specific scoring matrices (PSSM) and BWT                                                                                                                                   FASTQ

  CUSHAW2                              22576173   RNA         C++                   Uses Burrows-Wheeler transform (BWT), the Ferragina-Manzini index and CUDA parallel programming model for GPUs. Supports only ungapped alignment                                                                                          FASTQ

  DistMap             2013             24009693   RNA         Perl, Java            Wrapper for many aligners, based on MapReduc API for parallel processing. Currently not handling spliced alignments                                                                                                                       FASTQ

  MAQ                 2008             18714091   RNA         C++, Perl             Based on Smith-Waterman gapped alignment and Bayesian statistical model that incorporates the mapping qualities and error probabilities                                                                                                   FASTQ

  MOSAIK              2014             24599324   RNA         C++                   Uses hash clustering strategy coupled with the Smith-Waterman algorithm. Detects mismatches, short insertions and deletions                                                                                                               FASTQ

  PASS                2009             19218350   RNA         C++                   Based on precomputed score tables (PST) calculated with the Needleman and Wunsch algorithm                                                                                                                                                FASTQ

  RMAP                2009             19736251   RNA         C++                   Uses multiple filtration (Pevzner and Waterman) and approximate pattern matching.\                                                                                                                                                        FASTQ, FASTA
                                                                                    Incorporates the use of quality scores directly into the mapping process                                                                                                                                                                  

  SOAPaligner/SOAP2   2009             19497933   RNA         C                     Based on Burrows Wheeler Transformation (BWT) compression index                                                                                                                                                                           FASTQ

  Stampy              2011             20980556   RNA         Python                Hybrid probabilistic model for mapping quality (measured by Phred score)                                                                                                                                                                  FASTQ

  ZOOM                2008             18684737   RNA                               Custom filtering model                                                                                                                                                                                                                    FASTQ
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Transcriptome sequencing produces reads from transcribed sequences with introns and intergenic regions excluded. Standard alignment algorithms, which handle mismatches and gaps, generally do not handle mapping reads spanning across exons. Tools for identifying novel splice junctions usually use standard algorithms in the first step and then derive exon positions, e.g. from clustering of mapped reads or reads mapped into introns at their last few bases. Even in de novo assembly, in some parallel algorithms, if the location of each individual read is not tracked the reads may still need to be aligned back to the assembly. Therefore, sequence mapping is essential to almost all NGS techniques. Quantitation of microRNA expression requires similar steps but reads are mapped to the mature and precursor sequences of known miRNAs collected in microRNA databases. Prediction of secondary structure and genomic cluster analysis is useful \[[@CIT0037]\].

Expression quantitation and identification of differential expression {#S0004}
=====================================================================

The expression level of each mRNA is measured by the number of sequenced fragments that map to the transcript (or counts and its derivatives), which is expected to correlate directly with its abundance level. Counts usually refer to the number of reads that align to a particular genomic feature. Like gene counts, any other targets may be quantified, including exons, transcripts, and miRNAs. Counts are heavily dependent on RNA sequencing depth and the effective length of the feature. Therefore, counts need to be adjusted for feature length to make the expression comparable. Effective gene counts are adjusted for the amount of bias in the experiment. Counts per million (CPM) mapped reads are counts scaled by the number of sequenced fragments multiplied by one million. CPM\'s length-normalised analogues are reads per kilobase per million (RPKM) and fragment per kilobase per million (FPKM). RPKM and FPKM are identical for single-end sequencing but differ for the paired-end sequencing. Calculating length-normalised measures makes them comparable within a sample. The RSEM package computes maximum likelihood abundance estimates using the Expectation-Maximisation algorithm and effectively takes care of multi-mapping reads. The RSEM representation is a current standard for reporting expression by Firehose GDAC pipeline.

A deficiency of the RPKM/FPKM approach is that the proportional representation of each gene is dependent on the expression levels of all other genes. Often a small fraction of genes account for large proportions of the sequenced reads, and small expression changes in these highly expressed genes will skew the counts of lowly expressed genes under this scheme. This can result in deduction of erroneous differential expression. Therefore, methods for calculating differential expression require counts to begin with. Thus RNA-Seq non-negative counts follow discrete distribution as opposed to the intensities recorded from microarrays, which are treated as continuous measurements and commonly assumed to follow a log-normal distribution. For RNA-Seq data Poisson distribution and Negative Binomial (NB) distribution are the two most commonly used models \[[@CIT0038]--[@CIT0042]\] ([Table 3](#T0003){ref-type="table"}). Other distributions, such as beta-binomial \[[@CIT0043]\], have also been proposed.

###### 

Software for RNA-Seq data analysis

  Method name                                     Year published   PMID       Data type   Platform                     Statistical method                                                  Input requirements
  ----------------------------------------------- ---------------- ---------- ----------- ---------------------------- ------------------------------------------------------------------- ---------------------------------------------------------------------------
  Aldex                                           2013             23843979   RNA-seq     R                            ANOVA, Dirichlet distribution                                       Raw counts
  ALDEx2                                          2014             24910773   RNA-seq     R                            Dirichlet distribution, glm                                         Raw counts
  ASC                                             2010             21080965   RNA-seq     R                            Empirical Bayes,                                                    Raw counts
  baySeq                                          2010             20698981   RNA-seq     R                            Empirical Bayes                                                     Raw counts
  BBSeq                                           2011             21810900   RNA-seq     R                            Beta-Binomial, linear model                                         Raw counts
  CEDER                                           2012             22641709   RNA-seq     R                            Negative binomial                                                   Raw counts
  campcodeR (uses edgeR & DESeq)                  2014             24813215   RNA-seq     R                            Empirical Bayes                                                     Raw counts
  COV2HTML (not working)                          2014             24512253   RNA-seq     Web site                                                                                         
  CPTRA                                           2009             19811681   RNA-seq     Python                       ???                                                                 Long-read sequence w/ annotation, short-read sequence tag // fasta, fastq
  CQN                                             2012             22285995   RNA-seq     R                            Conditional quantile normalisation, robust generalised regression   Raw counts
  Cuffdiff                                        2013             23222703   RNA-seq     Standalone                   Beta negative binomial distribution                                 
  DegPack                                         2013             24981075   RNA-seq     Web site                     Non-parametric (ranks)                                              Raw counts
  DEGseq                                          2010             19855105   RNA-seq     R                            MA-plot-based (?)                                                   Raw counts
  DER Finder                                      2014             24398039   RNA-seq     R                            Hidden Markov Model                                                 Raw counts
  DESeq                                           2010             20979621   RNA-seq     R                            Negative binomial distribution                                      Raw counts
  DEXUS                                           2013             24049071   RNA-seq     R                            Expectation-maximisation algorithm, Bayes                           Raw counts
  EBSeq                                           2013             23428641   RNA-seq     R                            Empirical Bayes                                                     Raw counts
  EDASeq (users edgeR & DESeq)                    2011             22177264   RNA-seq     R                            Empirical Bayes                                                     Raw counts
  edgeR                                           2012             22287627   RNA-seq     R                            Empirical Bayes, glm                                                Raw counts
  edgeR-robust                                    2014             24753412   RNA-seq     R                            Weights, empirical Bayes                                            Raw counts
  GExposer                                                                                                             Machine learning algorithm                                          
  iFad                                            2012             22581178   RNA-seq     R                            Bayesian sparse factor model                                        Raw counts
  MRFSEQ (uses DESeq)                             2013             23793751   RNA-seq     Standalone                   Markov random field model                                           Raw counts, co-expression database
  Myrna                                           2010             20701754   RNA-seq     Cloud-computing, Bowtie, R                                                                       
  NOISeq                                          2011             21903743   RNA-seq     R                            Non-parametric                                                      Raw counts
  NPEBseq                                         2013             23981227   RNA-seq     R                            Non-parametric Bayesian                                             Raw counts
  pairedBayes                                                                 RNA-seq     R                            Empirical Bayes                                                     Raw counts
  PoissonSeq                                      2012             22003245   RNA-seq     R                            Poisson goodness-of-fit                                             Raw counts
  QuasiSeq                                        2012             23104842   RNA-seq     R                            Quasi-Poisson, quasi-negative binomial                              Raw counts
  RNASeqGUI (uses edgeR, DESeq, NoiSeq, BaySeq)   2014             24812338   RNA-seq     R                            Empirical Bayes, negative binomial                                  Raw counts
  SAMSeq                                          2013             22127579   RNA-seq     Standalone                   Non-parametric                                                      Raw counts
  ShrinkBaye                                      2014             24766777   RNA-seq     R                            Negative binomial, Poisson-Gaussian, Bayesian GLM                   Raw counts
  sSeq                                            2013             23589650   RNA-seq     R                            Negative Binomial                                                   Raw Counts
  TCC (uses edgeR, DESeq, DESeq2)                 2013             23837715   RNA-seq     R                            Negative Binomial, Empirical Bayes                                  Raw counts
  tRanslatome                                     2013             24222209   RNA-seq     R                            Rank Product, t-test, SAM, limma, ANOTA, DESeq, edgeR               Raw counts
  TSPM.R                                                                                                                                                                                   
  tweeDEseq                                       2013             23965047   RNA-seq     R                            Poisson-Tweedie distributions                                       Raw counts

The Poisson distribution has the advantage of simplicity and has only one parameter, but it constrains the variance of the modelled variable to be equal to the mean. The Negative Binomial distribution has two parameters, encoding the mean and the dispersion, and hence allows modelling of more general mean-variance relationships. For RNA-seq, it has been suggested that the Poisson distribution is well suited for analysis of technical replicates, whereas the higher variability between biological replicates necessitates a distribution incorporating overdispersion, such as Negative Binomial \[[@CIT0028], [@CIT0044], [@CIT0045]\]. Analogous to microarray data analysis, it is clear that borrowing the variance from other genes help to better estimate the variation in read counts for a gene and condition. This overcomes a common problem with an underestimation of variance when based on a low number of observations. The most commonly used parametric methods include EdgeR, DESeq, and baySeq and use negative binomial distribution. Other methods such as Cuffdiff2 uses a beta-negative binomial distribution, which is a combination of beta and negative binomial distribution. Non-parametric methods like SAM-Seq also work relatively well on the count data.

Identification of alternative splicing from transcriptomic reads {#S0005}
================================================================

A widely recognised source of proteome diversity in eukaryotic species is expression of multiple distinct mRNA transcripts from a single gene locus by alternative transcript initiation, alternative splicing \[[@CIT0047]\] ([Table 4](#T0004){ref-type="table"}), and alternative polyadenylation \[[@CIT0048]\]. If RNA-Seq reads span exon junctions, parts of reads will map to two different exons. This allows inference of alternative splicing. However, such a read structure will pose problems to standard aligners that map reads contiguously to the reference. Splice sites can be detected initially by identifying reads that span exon junctions. Split-read aligners such as TopHat, methods that identify minimal match on either side of exon junction, and genomic short-read nucleotide alignment are used to identify alternative splicing. Most methods utilise a database of expression and alternative expression sequence 'features'. These and other strategies that perform de-novo assemblies present a number of computational challenges because of computation time and the depth of sequencing, which results in few junction-spanning reads. This quantitation of alternatively spliced transcripts needs to be followed by identification of differential expression of these transcripts between samples.

###### 

Alternative splicing algorithm

  Method name   Year published   PMID       Data type   Platform            Statistical method                                                                                                                                                                                               Input requirements
  ------------- ---------------- ---------- ----------- ------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------
  ABMapper      2011             21169377   RNA         C++, Perl           Fast suffix-array algorithm and a dual-seed strategy for spliced alignment                                                                                                                                       FASTA, FASTQ
  ERANGE        2008             18516045   RNA         Python              Splice junctions identification relies on reference genome exon positions                                                                                                                                        FASTQ
  GEM Mapper    2012             23103880   RNA         C, Objective Caml   Based on Burrows-Wheeler Transform and custom mapping algorithms. Uses custom mappability concept                                                                                                                FASTQ
  MapSplice     2010             20802226   RNA         C++, Python         Algorithm not dependent on splice site features or intron length; consequently, it can detect novel canonical as well as non-canonical splices. This method has tag alignment phase and splice inference phase   FASTQ
  PALMapper     2010             21154708   RNA         Web/ Galaxy         Combines GenomeMapper (based on BWT and k-mer indexes) read mapper with the spliced aligner QPALMA                                                                                                               FASTQ
  QPALMA        2008             18689821   RNA         C++, Python         SVM-based splice site predictor with the so-called 'weighted degree' kernel. Alignment based on extended BWT                                                                                                     FASTQ
  SpliceMap     2010             20371516   RNA         C++, Python         Cannoical GT-AG splice sites identification using half-read mapping                                                                                                                                              FASTQ
  SplitSeek     2010             20236510   RNA                             Candidate junction reads generation in intermediate BEDPE format feasible for paired-end sequences                                                                                                               FASTQ
  Subread       2013             23558742   RNA         R                   Seed-and-vote - new multi-seed alignment strategy for overlapping seeds from each read (subreads)                                                                                                                FASTQ
  TopHat        2009             19289445   RNA         C++                 Canonical GT--AG splice sites identification                                                                                                                                                                     FASTQ

Apart from detection and quantitation of expression and alternative splicing, RNAseq has the capacity to identify RNA editing events \[[@CIT0049]--[@CIT0051]\], allele-specific expression (ASE) \[[@CIT0052], [@CIT0053]\], quantify noncoding RNAs \[[@CIT0054], [@CIT0055]\], and detect exogenous RNA \[[@CIT0056], [@CIT0057]\], single-nucleotide polymorphisms (SNPs), somatic mutations \[[@CIT0008], [@CIT0058]\], and structural variations.

Detection of somatic copy number alterations and structural variants {#S0006}
====================================================================

Genomic alterations accumulate in tumours during cancer development \[[@CIT0059]\]. In addition to point-mutations, inversions, and translocations, somatic copy-number alterations (SCNAs) are ubiquitous in cancer \[[@CIT0060], [@CIT0061]\], and several recurrent SCNAs are associated with particular cancer types \[[@CIT0062]\], tumour aggressiveness \[[@CIT0063]\], and patient prognosis \[[@CIT0064]\]. Reliable detection of SCNAs can lead to identification of cancer driver genes \[[@CIT0065]\] and development of new therapeutic approaches \[[@CIT0066]--[@CIT0068]\]. Deep sequencing \[[@CIT0069]\] and exome-based sequencing efforts are now replacing microarray-based array CGH (aCGH) \[[@CIT0070]\] and single nucleotide polymorphism arrays (SNP arrays) \[[@CIT0023], [@CIT0071]\]. Moreever, similarly to microarray-based studies, the inference about cancer related copy number alterations requires comparison of paired samples -- normal and tumour.

The general workflow to detect SCNAs from sequencing data consists of three main steps: (i) raw copy-number inference in the local genome region by either calculating read counts or depth of coverage ratio between tumour and control samples, (ii) the raw copy-number profiles segmentation to find change-points in the raw copy-number signal and divide the chromosomes accordingly into segments with similar copy-numbers, and (iii) classification of different segments into gains or losses. The first step is essentially based on understanding variations in depth of coverage (DOC) of aligned sequence reads against the reference genome \[[@CIT0069], [@CIT0072], [@CIT0073]\]. Deviation from the background in DOC may signify the presence of a copy number variation (CNV). The last two steps for obtaining copy number alteration are not specific to the sequencing data.

Multiple methods exist for identification of structural variations using whole genome sequencing. Methods include identification of atypical alignment patterns of sequence reads against the reference genome, which reflect gaps in the sequence alignment \[[@CIT0074]\]. In paired-end read mapping, the sequenced ends of a short DNA fragment are aligned against the reference genome. The mean insert size of the fragment is compared with the reference genome distance between aligned fragment ends to deduce the presence of deletions or insertions \[[@CIT0074]--[@CIT0076]\]. This detection requires high alignment accuracy and underscores its importance.

Although coding regions comprise only ∼1% of the genome, they are enriched for causal variation, making exome-based studies valuable, manageable, and cost-effective. Whole exome sequencing (WES) data have been used effectively for the identification of small INDELs, usually of a size \< 50 bp, within exon targets that are typically sized between 200 and 300 bp. The approaches discussed above, while appropriate for (deeply sequenced) DNA-sequencing data, are less effective for exome sequencing and detecting CNV, as the CNV\'s breakpoints are likely to lie outside the targeted exons \[[@CIT0077]\]. Detecting structural and copy number variations from RNA-Seq data presents similar challenges.

Identification of cancer driver mutations and their functional impact {#S0007}
=====================================================================

Cancer is abundantly composed of somatic mutations accumulating in the genome over an individual\'s lifetime, only a fraction of which drive cancer progression. Mutations can be identified from DNA-seq, RNA-seq, and Exome sequencing data \[[@CIT0078]--[@CIT0080]\] ([Table 5](#T0005){ref-type="table"}). The most basic way of detecting somatic mutations from NGS reads is to identify mismatch/gaps in the alignment of the read with the reference. However, large datasets possess sequencing errors: random mutations that occur during cell division and single nucleotide polymorphisms that differ from reference assembly. This makes identification of cancer driver mutations a challenging issue \[[@CIT0081]\]. Moreover, intra-tumour heterogeneity also hinders the identification of all types of somatic mutations \[[@CIT0082]\]. Several methods for detecting somatic mutations are currently in use, such as MuTect \[[@CIT0083]\], Strelka \[[@CIT0084]\], and VarScan 2 \[[@CIT0085]\] for SNV detection or BIC-Seq \[[@CIT0086]\], APOLLOH \[[@CIT0087]\], CoNIEFER \[[@CIT0088]\], BreakDancer \[[@CIT0089]\], and Meerkat \[[@CIT0087]\] for CNA or SV detection. Most methods for somatic mutation detection take into account only part of the possible source of errors; therefore, running different methods simultaneously is advisable.

###### 

Methods for finding mutations

  Method name              Year published   PMID       Data type   Platform     Statistical method                                                                                                       Input requirements
  ------------------------ ---------------- ---------- ----------- ------------ ------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------
  ActiveDriver             2013             23340843   DNA-seq     R            Generalized linear regression                                                                                            FASTA, TAB
  CancerMutationAnalysis   2014             24233780   DNA-seq     R            Empirical Bayes                                                                                                          Non-standard tables
  CanDrA                   2013             24205039   DNA-seq     Perl         U-Mann Whitney, AUC (area under curve)                                                                                   Non-standard tables
  CanPredict               2007             17537827   DNA-seq     Web site     SIFT, Pfam-based logR.E-value metric, GOSS                                                                               FASTA
  CAROL                    2012             22261837   DNA-seq     R            SIFT, PolyPhen-2                                                                                                         Tab-delimited, FASTA
  CHASM/SNV-Box            2009             19654296   DNA-seq     Standalone   CHASM, SNV-Box                                                                                                           dnSNP r\#, Pubmed ID, VCF, bed,
  CRAVAT                   2013             23325621   DNA-seq     Web site     CHASM, SnvGet                                                                                                            Non-standard tables
  DDIG-in                  2013             23497682   DNA-seq     Web site     Support vector machine-based method                                                                                      Non-standard tables
  DMI                      2012             23044540   DNA-seq     Standalone   Machine learning, discrimination index                                                                                   Text file
  DrGaP                    2013             23954162   DNA-seq     Standalone   Chi-square distribution                                                                                                  Non-standard tables
  e-Driver                 2014             25064568   DNA-seq     Perl         Binomial distribution                                                                                                    Non-standard tables
  eXtasy                   2013             24076761   DNA-seq     Web site     Variant impact prediction, haploinsufficiency prediction, phenotype-specific gene prioritisation                         VCF
  FATHMM                   2013             23620363   DNA-seq     Web site     Hidden Markov Model                                                                                                      Annotated VCF
  InVEx                    2012             22817889   DNA-seq     Python       Permutation-based                                                                                                        Non-standard tables, power FASTA
  MuSIC                    2012             22759861   DNA-seq     Standalone   Fisher p-value, likelihood ratio test, convolution test (summarised log statistic of joint binomial point probability)   BAM, SNV, MAF
  MutSig                   2013             23770567   DNA-seq     Standalone   MutSigCV (Background mutation rate)                                                                                      
  nsSNPAnalyzer            2005             15980516   DNA-seq     Web site     Machine learning (random forest)                                                                                         FASTA, SNP
  Oncodrive-fm             2012             22904074   DNA-seq     Standalone   SIFT, PolyPhen2, MutationAssessor                                                                                        TDM, TSV
  OncodriveCLUST           2013             23884480   DNA-seq     Python       Clustering                                                                                                               Non-standard tables
  PANTHER                  2013             23193289   DNA-seq     Web site     subPSEC                                                                                                                  FASTA
  PhD-SNP                  2006             16895930   DNA-seq     Web site     Sequence and Profile-Based                                                                                               FASTA
  PROVEAN                  2012             23056405   DNA-seq     Standalone   Alignment-Based                                                                                                          Non-standard tables
  transFIC                 2012             23181723   DNA-seq     Web site     SIFT, PolyPhen2, MutationAssessor                                                                                        File w/ chromosome/protein coordinates (hg19)

The most basic task for mutation analysis in cancer is the distinction between driver and passenger mutations. To help filter a subset of driver mutations from the long list of detected somatic and passenger mutations, three major computational predictive approaches utilising different statistical tests can be applied \[[@CIT0090]--[@CIT0092]\]:

\(1\) **Identification of recurrent somatic mutations** is based on the idea of clonal evolution of tumour cell populations. To predict genes with recurrent single-mutations in a cohort of cancer patients, several statistical methodologies including MutSigCV \[[@CIT0003]\], MuSiC \[[@CIT0093]\], and DrGaP \[[@CIT0094]\] are available. These methods are based on the determination of the probability of the observed number of mutations in a gene to the expected background mutation rate, the BMR (probability of observed passenger mutation) across a cohort of patients. As opposed to mutations, there is no accurate model established to identify genes with recurrent copy number aberrations (CNAs); therefore, methods are based on a non-parametric approach, e.g. GISTIC2 \[[@CIT0095]\], CMDS \[[@CIT0096]\], and ADMIRE \[[@CIT0097]\].

\(2\) **Prediction of the functional impact of individual mutations** is based on the utilisation of additional information about protein sequence and/or structure and evolutionary conservation of the protein encoded by the mutated gene. Methods like SIFT \[[@CIT0098]\], Polyphen-2 \[[@CIT0099]\], and MutationAssesor \[[@CIT0100]\] predict the functional impact (deleteriousness) of missense mutations. CHASM utilises random forest classification to identify driver and passenger somatic missense mutations, based on a training set of labelled positive (driver) and negative (passenger) examples \[[@CIT0101]\]. Furthermore, clusters of non-synonymous mutations across patients, typically to detect 'activating' mutations, NMC \[[@CIT0102]\] and the Invex \[[@CIT0103]\] method can be applied. Moreover, the iPAC method is able to search for clusters of mutations, but in the context of crystal structures of proteins \[[@CIT0104]\].

\(3\) **Identification of recurrent combinations of mutations** is based on assessment of combinations of mutations enriched in known pathways (e.g. GSEA \[[@CIT0105]\], Path-Scan \[[@CIT0106]\], Patient-oriented gene sets \[[@CIT0107]\]), interaction networks (NetBox \[[@CIT0108]\], HotNet \[[@CIT0109]\], MEMo \[[@CIT0110]\]), or de novo defined sets (Dendrix \[[@CIT0109]\], Muti-Dendrix \[[@CIT0111]\] or RME \[[@CIT0112]\]), enabling the discovery of novel combinations of mutated genes in cancer.

Identification of gene fusions {#S0008}
==============================

Gene fusions appear as a result of chromosomal rearrangements, such as deletion, insertion, inversion, or translocation. A fused gene is expressed as a hybrid entity encoding sequences of two distinct genes. Tumorigenic fusions successfully evade the gene regulation that its constituents are subjected to. Multiple cancer-related gene fusions have been identified, including prototypic BCR-ABL \[[@CIT0113]\], EML4-ALK \[[@CIT0114]\], TMPRSS2-ERG \[[@CIT0115]\], KIF5B-RET \[[@CIT0116]\], and others \[[@CIT0007], [@CIT0013], [@CIT0014], [@CIT0117]\]. Such alterations may serve as a good cancer biomarker or therapeutic target \[[@CIT0120], [@CIT0121]\]. Whole genome \[[@CIT0075], [@CIT0119]\] and transcriptome sequencing \[[@CIT0120], [@CIT0121]\] profiles can be used to identify fusions.

Transcriptome sequencing is proven to be superior over WGS and therefore is more commonly used. This is due to the fact that RNA-seq covers only transcribed sequences, which constitute a small percentage of the genome, thus reducing the cost, time, and resources needed for full analysis. Furthermore, RNA-seq provides information on the transcriptionally active fusion genes and their splicing variants. However, it also harbours certain limitations, including lack of information regarding non-transcribed regions and dependence on the heterogeneity in the expression levels between various cell types \[[@CIT0122]\]. Over the last few years several software packages ([Table 6](#T0006){ref-type="table"}) have been developed for the detection of gene fusions and/or structural variants (SV) that cause gene fusions. The majority of the software utilises RNA-seq data as an input. However, other tools use WGS data or both to increase the likelihood of detection of true fusion.

###### 

Identifying gene fusions

  Method name      Year published   PMID       Data type          Platform      Statistical method                                                                         Input requirements
  ---------------- ---------------- ---------- ------------------ ------------- ------------------------------------------------------------------------------------------ -------------------------------
  BreakFusion      2012             22563071   RNA-seq            C++, Perl     A computational pipeline for identifying gene fusions from RNA-seq data                    BAM
  BreakTrans       2013             23972288   RNA-seq            Perl          Uncovering the genomic architecture of gene fusions                                        Tab-delimited text files
  chimerascan      2011             21840877   RNA-seq            Python        Identifying chimeric transcription in sequencing data                                      FASTQ
  comrad           2011             21478487   RNA-seq, DNA-seq   C++           Discovery of gene fusions using paired end RNA-Seq and WGSS.                               FASTQ
  deFuse           2011             21625565   RNA-seq            C++           Detecting gene fusions from paired-end RNA-seq                                             FASTQ
  FusionAnalyser   2012             22570408   RNA-seq            C\#           Detecting gene fusions from paired-end RNA-Seq data                                        SAM/BAM
  FusionHunter     2011             21546395   RNA-seq            Perl          Detecting gene fusions from paired-end RNA-Seq data                                        FASTQ
  FusionMap        2011             21593131   RNA-seq, DNA-seq   C\#           Detecting gene fusions from single- and paired-end RNA-Seq and DNA-seq data                FASTQ/BAM with unmapped reads
  FusionSeq        2010             20964841   RNA-seq            C             A modular framework for finding gene fusions by analysing Paired-End RNA-Sequencing data   MRF, SAM
  ShortFuse        2011             21330288   RNA-seq            C++, Python   Detecting gene fusions from paired-end RNA-Seq data                                        FASTQ
  SnowShoes-FTD    2011             21622959   RNA-seq            Perl          Detecting gene fusions from paired-end RNA-Seq data                                        FASTQ
  SOAPfusion       2013             24123671   RNA-seq            Perl          Detecting gene fusions from paired-end RNA-Seq data                                        FASTQ
  TopHat-Fusion    2011             21835007   RNA-seq            C++           Detecting gene fusions from single- and paired-end RNA-Seq data                            FASTQ

The most common analysis steps for identifying gene fusions are as follows: (i) alignment and filtering, (ii) detection of fusion junctions in candidate genes, and (iii) fragment assembly and selection of putative fusions \[[@CIT0122]\]. Apart from mapping to the current reference genome available, RNA-seq reads are additionally mapped to annotated transcriptome libraries (e.g. RefSeq). The most commonly used mapping tool is Bowtie, due to its speed and high efficiency. The reads that map appropriately to the reference genome are filtered out from further analysis. The unmapped or discordantly mapped reads are fusion candidates that might be further passed through additional filters (e.g. ribosomal filter, repetitive region filter, short distance filter, etc.) to eliminate potential false negatives. Next, the reads remaining after filtration are divided into smaller fragments (so-called "split reads") with even or pre-defined length, and both terminal parts are independently aligned to the reference genome. If they map to two different genes, they are further subjected to detection of fusion junction. The sequences of both genes are put together according to the fusion boundary, and the whole read is re-aligned to the candidate fusion gene to call supporting reads essential for the final selection of fusion. Another approach for the detection of fusion intersection is grouping discordantly mapped reads ("spanning reads") according to the same breakpoints. Detection of fusion junction from such groups fuels prediction of the putative fusion transcript. Subsequently, the reads are re-aligned to predicted sequences and the predictions with the highest mapping scores aid identification of candidate fusion genes. The final selection of the fusion genes depends on several parameters including the number of supporting reads, quality of the alignment, and sequencing coverage \[[@CIT0122], [@CIT0123]\].

Estimating sample purity {#S0009}
========================

Most genomics and expression-profiling studies including TCGA use a mixture of different clonal populations of tumour cells, which is often contaminated with stromal and immune cells. Indeed, many common tumours, such as pancreatic tumours, are intensively infiltrated by stroma \[[@CIT0124]\] making it difficult to obtain homogenous material for genomic studies. Furthermore, epithelial cells are also often found in tumour samples, as they are at the interior surface of blood vessels necessary for providing nutrients for cancer cells. Methods like laser capture micro-dissection are rarely used in RNA-studies requiring stable material \[[@CIT0125]\]. Estimating purity and clonality of a tumour sample containing a mixed population of cells requires accurate measurement of the proportion of tumour and stromal cell samples. Over the years several different methods ([Table 7](#T0007){ref-type="table"}) have been developed to deconvolute genomic and transcriptomic data obtained from mixed-cell populations. Software packages based on these methods provide powerful tools for estimation of tumour heterogeneity and purity and in consequence identification of likely early driver events during tumorigenesis \[[@CIT0126]\].

###### 

Available software for purity estimation

  Method name                  Year published   PMID       Data type (technique)      Platform               Statistical method                                                    Input requirements
  ---------------------------- ---------------- ---------- -------------------------- ---------------------- --------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------
  Dsection                     2010             20631160   RNA (Microarray)           Web-based and MATLAB   Bayesian model                                                        Expression and proportion data required
  csSAM                        2010             20208531   RNA (Microarray)           \-                     Linear regression-based model                                         Expression profile of mixed tissue samples
  mixture_estimation.R         2010             20202973   RNA (Microarray)           R based                Variation of electronic subtraction method                            Expression profile of mixed tissue samples
  ASCAT                        2010             20837533   DNA (Microarray)           R based                Analytical optimisation method                                        SNP array data with Log R and B-Allele frequency information
  PERT                         2012             23284283   RNA (Microarray)           Octave                 Perturbation model                                                    Expression data from mixed cell type and expression profile of each homogeneous cell type
  ABSOLUTE                     2012             22544022   DNA (Microarray and HTS)   R based                Gaussian mixture model                                                Copy number data in segmentation file
  JointSNVMixl, JointSNVMix2   2012             22285562   DNA (HTS)                  Python                 Probabilistic graphical model                                         Sequence data from tumour/normal pairs
  CNAnorm                      2012             22039209   DNA (HTS)                  R based                Analytical optimization method                                        Sequencing data of tumour and normal samples in bam format
  DeconRNASeq                  2013             23428642   RNA (Microarray and HTS)   R based                Globally optimised nonnegative decomposition algorithm                Expression data from multiple tissue, signature of individual tissue and proportion data required
  TEMT                         2013             23735186   RNA (HTS)                  Python                 Probabilistic model including position and sequence-specific biases   Required RNA-seq sequencing data from pure tissue and mixed tissue
  ESTIMATE                     2013             24113773   RNA (HTS)                  R based                Gene signature (ssGSEA) based model                                   Expression data in Gene Set Enrichment Analysis (GSEA) gct format
  THetA                        2013             23895164   DNA (HTS)                  Python                 Explicit probabilistic model                                          Copy number data in interval count file format
  ExPANdS                      2013             24177718   DNA (HTS)                  R based and MATLAB     Probability distributions model                                       Somatic mutations and copy number data required
  Virmid                       2013             23987214   DNA (HTS)                  Java based             Probabilistic model and maximum likelihood estimator                  Disease and normal sequencing data in bam format
  MuTect                       2013             23396013   DNA (HTS)                  Java based             Bayesian model                                                        Tumour and normal sequencing data
  TrAp                         2013             23892400   DNA (HTS)                  Java based             Linear mixture model with evolutionary framework                      Tumour karyotypes and somatic hypermutation datasets
  Seo *et al*.                 2013             23650637   RNA (Microarray)           --                     Linear mixture model                                                  Disease-associated variants and expression of heterogeneous normal tissue

Comparative and integrative analysis of tumour samples {#S0010}
======================================================

One of the major achievements of the TCGA project is the generation of different types of data from the same sample for a large number of tumours. This data generation is followed by uniform data processing and correlation with clinical information by Firehose and other analysis pipelines at various genome data analysis centres. The availability of such paired data allows detection of functional impact on genomic lesions (e.g. mutations, copy numbers, and gene fusions) on gene/miRNA (using RNA-Seq) and protein expression (using RPPA arrays) and pathway levels while reducing errors due to individual patient variation. Another example is the utilisation of multiple data types to identify integrated subtypes for a given tumour type using the iCLUSTER method \[[@CIT0013], [@CIT0014], [@CIT0127]\]. Other approaches include integration of pathway information (e.g. PARADIGM & Paradigm-shift) and regulatory network information (e.g. GEMINI -- \[[@CIT0128]\]).

Comparative analysis of multiple tumour types increases the statistical power to detect common events that drive tumorigenesis and repurpose the therapy. For example, *ERBB2-HER2* is mutated and/or amplified in subsets of glioblastoma, gastric, serous endometrial, bladder, and lung cancers. The result, at least in some cases, is responsiveness to HER2-targeted therapy, analogous to that previously observed for *HER2*-amplified breast cancer. There are more examples that underscore the importance of such comparative analysis \[[@CIT0004]\].

Future of cancer profile analysis {#S0011}
=================================

As we are entering the era of \$1000 genome sequencing, tumour profiles are being sequenced routinely. Moreover, tumour catalogues and pre-clinical models \[[@CIT0129], [@CIT0130]\] have similar types of information available, with or without drug treatments. Integration of such datasets can speed up pre-clinical drug development and repurposing of available drugs. Tumour profiling by sequencing is also expected to enter both the pre-clinical and clinical setting for standardised testing as well as personalisation of medicine. However, the sequencing data fits the definition of "big data", and a reliable computational infrastructure for storage, processing, analysis, and visualisation \[[@CIT0131], [@CIT0132]\] is required to make most of this avalanche of information \[[@CIT0133]\]. Indeed, ambitious efforts like the cancer moonshot program and APOLLO launched by the UT MD Anderson Cancer Centre, aim to combine big data warehousing with IBM WATSON based cognitive and adaptive learning to reduce cancer mortality for several tumour types, will fully realise the power of tumour profiling.

Authors declare no conflict of interest.

The authors thank Hubert Świerczyński, Wojciech Pieklik, Juliusz Pukacki, and Dr Cezary Mazurek from the Poznan Supercomputing and Networking Centre affiliated to the Institute of Bioorganic Chemistry of the Polish Academy of Sciences for their help in preparation of the tables. This work was supported by the Foundation for Polish Science Welcome program grant No: 2010-3/3 to Maciej Wiznerowicz and UT MD Anderson Cancer Center intramural grants.
